Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE

BACKGROUND: The REFINE study examined the efficacy and safety of adding topical corticosteroid therapy to etanercept when stepping down from the initial dose of etanercept to the maintenance dose. Clinical responses were shown to be similar in patients who remained on etanercept 50 mg twice weekly (...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, K.A., Barber, K., Bissonnette, R., Bourcier, M., Lynde, C.W., Poulin, Y., Shelton, J., Garces, K., Toole, J., Poulin‐Costello, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024053/
https://www.ncbi.nlm.nih.gov/pubmed/25611084
http://dx.doi.org/10.1111/jdv.12934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024053/
https://www.ncbi.nlm.nih.gov/pubmed/25611084
http://dx.doi.org/10.1111/jdv.12934

Ejemplares similares